nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0777	0.153	CbGbCtD
Oxybutynin—CYP3A5—Dexamethasone—psoriatic arthritis	0.0754	0.148	CbGbCtD
Oxybutynin—CYP2C8—Dexamethasone—psoriatic arthritis	0.0725	0.143	CbGbCtD
Oxybutynin—CYP3A4—Triamcinolone—psoriatic arthritis	0.0589	0.116	CbGbCtD
Oxybutynin—CYP3A4—Betamethasone—psoriatic arthritis	0.0505	0.0995	CbGbCtD
Oxybutynin—CYP3A4—Prednisolone—psoriatic arthritis	0.0499	0.0982	CbGbCtD
Oxybutynin—CYP3A4—Prednisone—psoriatic arthritis	0.0471	0.0927	CbGbCtD
Oxybutynin—CYP2D6—Dexamethasone—psoriatic arthritis	0.0462	0.0911	CbGbCtD
Oxybutynin—CYP3A4—Dexamethasone—psoriatic arthritis	0.0294	0.0579	CbGbCtD
Oxybutynin—Anxiety—Methylprednisolone—psoriatic arthritis	0.000711	0.00145	CcSEcCtD
Oxybutynin—Infestation—Methotrexate—psoriatic arthritis	0.00071	0.00144	CcSEcCtD
Oxybutynin—Infestation NOS—Methotrexate—psoriatic arthritis	0.00071	0.00144	CcSEcCtD
Oxybutynin—Drowsiness—Methotrexate—psoriatic arthritis	0.00071	0.00144	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000709	0.00144	CcSEcCtD
Oxybutynin—Depression—Methotrexate—psoriatic arthritis	0.000708	0.00144	CcSEcCtD
Oxybutynin—Flushing—Prednisone—psoriatic arthritis	0.000708	0.00144	CcSEcCtD
Oxybutynin—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000708	0.00144	CcSEcCtD
Oxybutynin—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000708	0.00144	CcSEcCtD
Oxybutynin—Discomfort—Triamcinolone—psoriatic arthritis	0.000707	0.00144	CcSEcCtD
Oxybutynin—Discomfort—Methylprednisolone—psoriatic arthritis	0.000705	0.00143	CcSEcCtD
Oxybutynin—Dry mouth—Triamcinolone—psoriatic arthritis	0.0007	0.00142	CcSEcCtD
Oxybutynin—Angioedema—Betamethasone—psoriatic arthritis	0.000697	0.00142	CcSEcCtD
Oxybutynin—Angioedema—Dexamethasone—psoriatic arthritis	0.000697	0.00142	CcSEcCtD
Oxybutynin—Stomatitis—Methotrexate—psoriatic arthritis	0.000692	0.00141	CcSEcCtD
Oxybutynin—Angiopathy—Prednisone—psoriatic arthritis	0.000692	0.00141	CcSEcCtD
Oxybutynin—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00069	0.0014	CcSEcCtD
Oxybutynin—Confusional state—Methylprednisolone—psoriatic arthritis	0.00069	0.0014	CcSEcCtD
Oxybutynin—Malaise—Dexamethasone—psoriatic arthritis	0.000688	0.0014	CcSEcCtD
Oxybutynin—Malaise—Betamethasone—psoriatic arthritis	0.000688	0.0014	CcSEcCtD
Oxybutynin—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000686	0.00139	CcSEcCtD
Oxybutynin—Oedema—Triamcinolone—psoriatic arthritis	0.000686	0.00139	CcSEcCtD
Oxybutynin—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000684	0.00139	CcSEcCtD
Oxybutynin—Syncope—Betamethasone—psoriatic arthritis	0.000684	0.00139	CcSEcCtD
Oxybutynin—Syncope—Dexamethasone—psoriatic arthritis	0.000684	0.00139	CcSEcCtD
Oxybutynin—Arrhythmia—Prednisone—psoriatic arthritis	0.000682	0.00138	CcSEcCtD
Oxybutynin—Infection—Triamcinolone—psoriatic arthritis	0.000681	0.00138	CcSEcCtD
Oxybutynin—Infection—Methylprednisolone—psoriatic arthritis	0.00068	0.00138	CcSEcCtD
Oxybutynin—Haematuria—Methotrexate—psoriatic arthritis	0.000677	0.00138	CcSEcCtD
Oxybutynin—Shock—Triamcinolone—psoriatic arthritis	0.000675	0.00137	CcSEcCtD
Oxybutynin—Insomnia—Prednisolone—psoriatic arthritis	0.000675	0.00137	CcSEcCtD
Oxybutynin—Shock—Methylprednisolone—psoriatic arthritis	0.000673	0.00137	CcSEcCtD
Oxybutynin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000671	0.00136	CcSEcCtD
Oxybutynin—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00067	0.00136	CcSEcCtD
Oxybutynin—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00067	0.00136	CcSEcCtD
Oxybutynin—Epistaxis—Methotrexate—psoriatic arthritis	0.00067	0.00136	CcSEcCtD
Oxybutynin—Paraesthesia—Prednisolone—psoriatic arthritis	0.00067	0.00136	CcSEcCtD
Oxybutynin—Tachycardia—Triamcinolone—psoriatic arthritis	0.000669	0.00136	CcSEcCtD
Oxybutynin—Mental disorder—Prednisone—psoriatic arthritis	0.000668	0.00136	CcSEcCtD
Oxybutynin—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000668	0.00136	CcSEcCtD
Oxybutynin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000665	0.00135	CcSEcCtD
Oxybutynin—Erythema—Prednisone—psoriatic arthritis	0.000664	0.00135	CcSEcCtD
Oxybutynin—Malnutrition—Prednisone—psoriatic arthritis	0.000664	0.00135	CcSEcCtD
Oxybutynin—Convulsion—Dexamethasone—psoriatic arthritis	0.000661	0.00134	CcSEcCtD
Oxybutynin—Convulsion—Betamethasone—psoriatic arthritis	0.000661	0.00134	CcSEcCtD
Oxybutynin—Hypertension—Dexamethasone—psoriatic arthritis	0.000658	0.00134	CcSEcCtD
Oxybutynin—Hypertension—Betamethasone—psoriatic arthritis	0.000658	0.00134	CcSEcCtD
Oxybutynin—Anxiety—Dexamethasone—psoriatic arthritis	0.000647	0.00131	CcSEcCtD
Oxybutynin—Anxiety—Betamethasone—psoriatic arthritis	0.000647	0.00131	CcSEcCtD
Oxybutynin—Discomfort—Dexamethasone—psoriatic arthritis	0.000641	0.0013	CcSEcCtD
Oxybutynin—Discomfort—Betamethasone—psoriatic arthritis	0.000641	0.0013	CcSEcCtD
Oxybutynin—Hypotension—Methylprednisolone—psoriatic arthritis	0.00064	0.0013	CcSEcCtD
Oxybutynin—Pain—Prednisolone—psoriatic arthritis	0.000638	0.0013	CcSEcCtD
Oxybutynin—Pharyngitis—Methotrexate—psoriatic arthritis	0.000633	0.00129	CcSEcCtD
Oxybutynin—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00063	0.00128	CcSEcCtD
Oxybutynin—Vision blurred—Prednisone—psoriatic arthritis	0.000626	0.00127	CcSEcCtD
Oxybutynin—Urethral disorder—Methotrexate—psoriatic arthritis	0.000625	0.00127	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000625	0.00127	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000624	0.00127	CcSEcCtD
Oxybutynin—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000622	0.00126	CcSEcCtD
Oxybutynin—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000622	0.00126	CcSEcCtD
Oxybutynin—Oedema—Betamethasone—psoriatic arthritis	0.000622	0.00126	CcSEcCtD
Oxybutynin—Oedema—Dexamethasone—psoriatic arthritis	0.000622	0.00126	CcSEcCtD
Oxybutynin—Insomnia—Triamcinolone—psoriatic arthritis	0.00062	0.00126	CcSEcCtD
Oxybutynin—Insomnia—Methylprednisolone—psoriatic arthritis	0.000619	0.00126	CcSEcCtD
Oxybutynin—Infection—Betamethasone—psoriatic arthritis	0.000618	0.00126	CcSEcCtD
Oxybutynin—Infection—Dexamethasone—psoriatic arthritis	0.000618	0.00126	CcSEcCtD
Oxybutynin—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000616	0.00125	CcSEcCtD
Oxybutynin—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000616	0.00125	CcSEcCtD
Oxybutynin—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000615	0.00125	CcSEcCtD
Oxybutynin—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000615	0.00125	CcSEcCtD
Oxybutynin—Visual impairment—Methotrexate—psoriatic arthritis	0.000614	0.00125	CcSEcCtD
Oxybutynin—Shock—Dexamethasone—psoriatic arthritis	0.000612	0.00124	CcSEcCtD
Oxybutynin—Shock—Betamethasone—psoriatic arthritis	0.000612	0.00124	CcSEcCtD
Oxybutynin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00061	0.00124	CcSEcCtD
Oxybutynin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00061	0.00124	CcSEcCtD
Oxybutynin—Agitation—Prednisone—psoriatic arthritis	0.00061	0.00124	CcSEcCtD
Oxybutynin—Tachycardia—Dexamethasone—psoriatic arthritis	0.000607	0.00123	CcSEcCtD
Oxybutynin—Tachycardia—Betamethasone—psoriatic arthritis	0.000607	0.00123	CcSEcCtD
Oxybutynin—Angioedema—Prednisone—psoriatic arthritis	0.000607	0.00123	CcSEcCtD
Oxybutynin—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000604	0.00123	CcSEcCtD
Oxybutynin—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000602	0.00122	CcSEcCtD
Oxybutynin—Malaise—Prednisone—psoriatic arthritis	0.000599	0.00122	CcSEcCtD
Oxybutynin—Eye disorder—Methotrexate—psoriatic arthritis	0.000596	0.00121	CcSEcCtD
Oxybutynin—Syncope—Prednisone—psoriatic arthritis	0.000596	0.00121	CcSEcCtD
Oxybutynin—Tinnitus—Methotrexate—psoriatic arthritis	0.000594	0.00121	CcSEcCtD
Oxybutynin—Anorexia—Betamethasone—psoriatic arthritis	0.000593	0.00121	CcSEcCtD
Oxybutynin—Anorexia—Dexamethasone—psoriatic arthritis	0.000593	0.00121	CcSEcCtD
Oxybutynin—Urticaria—Prednisolone—psoriatic arthritis	0.000593	0.0012	CcSEcCtD
Oxybutynin—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000592	0.0012	CcSEcCtD
Oxybutynin—Fatigue—Triamcinolone—psoriatic arthritis	0.000591	0.0012	CcSEcCtD
Oxybutynin—Fatigue—Methylprednisolone—psoriatic arthritis	0.00059	0.0012	CcSEcCtD
Oxybutynin—Pain—Triamcinolone—psoriatic arthritis	0.000587	0.00119	CcSEcCtD
Oxybutynin—Loss of consciousness—Prednisone—psoriatic arthritis	0.000584	0.00119	CcSEcCtD
Oxybutynin—Hypotension—Dexamethasone—psoriatic arthritis	0.000582	0.00118	CcSEcCtD
Oxybutynin—Hypotension—Betamethasone—psoriatic arthritis	0.000582	0.00118	CcSEcCtD
Oxybutynin—Angiopathy—Methotrexate—psoriatic arthritis	0.000578	0.00118	CcSEcCtD
Oxybutynin—Convulsion—Prednisone—psoriatic arthritis	0.000575	0.00117	CcSEcCtD
Oxybutynin—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000575	0.00117	CcSEcCtD
Oxybutynin—Hypertension—Prednisone—psoriatic arthritis	0.000573	0.00116	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000567	0.00115	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000567	0.00115	CcSEcCtD
Oxybutynin—Arthralgia—Prednisone—psoriatic arthritis	0.000565	0.00115	CcSEcCtD
Oxybutynin—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000565	0.00115	CcSEcCtD
Oxybutynin—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000564	0.00115	CcSEcCtD
Oxybutynin—Anxiety—Prednisone—psoriatic arthritis	0.000563	0.00114	CcSEcCtD
Oxybutynin—Insomnia—Dexamethasone—psoriatic arthritis	0.000563	0.00114	CcSEcCtD
Oxybutynin—Insomnia—Betamethasone—psoriatic arthritis	0.000563	0.00114	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000561	0.00114	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00056	0.00114	CcSEcCtD
Oxybutynin—Paraesthesia—Betamethasone—psoriatic arthritis	0.000559	0.00114	CcSEcCtD
Oxybutynin—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000559	0.00114	CcSEcCtD
Oxybutynin—Discomfort—Prednisone—psoriatic arthritis	0.000559	0.00113	CcSEcCtD
Oxybutynin—Mental disorder—Methotrexate—psoriatic arthritis	0.000559	0.00113	CcSEcCtD
Oxybutynin—Malnutrition—Methotrexate—psoriatic arthritis	0.000555	0.00113	CcSEcCtD
Oxybutynin—Erythema—Methotrexate—psoriatic arthritis	0.000555	0.00113	CcSEcCtD
Oxybutynin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00055	0.00112	CcSEcCtD
Oxybutynin—Dyspepsia—Betamethasone—psoriatic arthritis	0.000548	0.00111	CcSEcCtD
Oxybutynin—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000548	0.00111	CcSEcCtD
Oxybutynin—Urticaria—Triamcinolone—psoriatic arthritis	0.000545	0.00111	CcSEcCtD
Oxybutynin—Urticaria—Methylprednisolone—psoriatic arthritis	0.000544	0.0011	CcSEcCtD
Oxybutynin—Dysgeusia—Methotrexate—psoriatic arthritis	0.000544	0.0011	CcSEcCtD
Oxybutynin—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000542	0.0011	CcSEcCtD
Oxybutynin—Oedema—Prednisone—psoriatic arthritis	0.000542	0.0011	CcSEcCtD
Oxybutynin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000541	0.0011	CcSEcCtD
Oxybutynin—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000541	0.0011	CcSEcCtD
Oxybutynin—Decreased appetite—Betamethasone—psoriatic arthritis	0.000541	0.0011	CcSEcCtD
Oxybutynin—Infection—Prednisone—psoriatic arthritis	0.000538	0.00109	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000537	0.00109	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000537	0.00109	CcSEcCtD
Oxybutynin—Back pain—Methotrexate—psoriatic arthritis	0.000537	0.00109	CcSEcCtD
Oxybutynin—Fatigue—Betamethasone—psoriatic arthritis	0.000537	0.00109	CcSEcCtD
Oxybutynin—Fatigue—Dexamethasone—psoriatic arthritis	0.000537	0.00109	CcSEcCtD
Oxybutynin—Shock—Prednisone—psoriatic arthritis	0.000533	0.00108	CcSEcCtD
Oxybutynin—Pain—Betamethasone—psoriatic arthritis	0.000532	0.00108	CcSEcCtD
Oxybutynin—Pain—Dexamethasone—psoriatic arthritis	0.000532	0.00108	CcSEcCtD
Oxybutynin—Nervous system disorder—Prednisone—psoriatic arthritis	0.000532	0.00108	CcSEcCtD
Oxybutynin—Tachycardia—Prednisone—psoriatic arthritis	0.000529	0.00107	CcSEcCtD
Oxybutynin—Skin disorder—Prednisone—psoriatic arthritis	0.000526	0.00107	CcSEcCtD
Oxybutynin—Vision blurred—Methotrexate—psoriatic arthritis	0.000523	0.00106	CcSEcCtD
Oxybutynin—Anorexia—Prednisone—psoriatic arthritis	0.000517	0.00105	CcSEcCtD
Oxybutynin—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000515	0.00105	CcSEcCtD
Oxybutynin—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000513	0.00104	CcSEcCtD
Oxybutynin—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000513	0.00104	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000509	0.00103	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000509	0.00103	CcSEcCtD
Oxybutynin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000505	0.00103	CcSEcCtD
Oxybutynin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000504	0.00102	CcSEcCtD
Oxybutynin—Malaise—Methotrexate—psoriatic arthritis	0.000501	0.00102	CcSEcCtD
Oxybutynin—Urticaria—Betamethasone—psoriatic arthritis	0.000494	0.001	CcSEcCtD
Oxybutynin—Urticaria—Dexamethasone—psoriatic arthritis	0.000494	0.001	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000494	0.001	CcSEcCtD
Oxybutynin—Dizziness—Prednisolone—psoriatic arthritis	0.000493	0.001	CcSEcCtD
Oxybutynin—Asthenia—Triamcinolone—psoriatic arthritis	0.000492	0.001	CcSEcCtD
Oxybutynin—Abdominal pain—Betamethasone—psoriatic arthritis	0.000492	0.001	CcSEcCtD
Oxybutynin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000492	0.001	CcSEcCtD
Oxybutynin—Asthenia—Methylprednisolone—psoriatic arthritis	0.000491	0.000998	CcSEcCtD
Oxybutynin—Insomnia—Prednisone—psoriatic arthritis	0.00049	0.000996	CcSEcCtD
Oxybutynin—Paraesthesia—Prednisone—psoriatic arthritis	0.000487	0.000989	CcSEcCtD
Oxybutynin—Pruritus—Triamcinolone—psoriatic arthritis	0.000485	0.000986	CcSEcCtD
Oxybutynin—Cough—Methotrexate—psoriatic arthritis	0.000484	0.000984	CcSEcCtD
Oxybutynin—Pruritus—Methylprednisolone—psoriatic arthritis	0.000484	0.000984	CcSEcCtD
Oxybutynin—Convulsion—Methotrexate—psoriatic arthritis	0.000481	0.000977	CcSEcCtD
Oxybutynin—Dyspepsia—Prednisone—psoriatic arthritis	0.000477	0.000969	CcSEcCtD
Oxybutynin—Chest pain—Methotrexate—psoriatic arthritis	0.000473	0.00096	CcSEcCtD
Oxybutynin—Arthralgia—Methotrexate—psoriatic arthritis	0.000473	0.00096	CcSEcCtD
Oxybutynin—Decreased appetite—Prednisone—psoriatic arthritis	0.000471	0.000957	CcSEcCtD
Oxybutynin—Rash—Prednisolone—psoriatic arthritis	0.00047	0.000956	CcSEcCtD
Oxybutynin—Dermatitis—Prednisolone—psoriatic arthritis	0.00047	0.000955	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000469	0.000953	CcSEcCtD
Oxybutynin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000468	0.000951	CcSEcCtD
Oxybutynin—Fatigue—Prednisone—psoriatic arthritis	0.000467	0.000949	CcSEcCtD
Oxybutynin—Headache—Prednisolone—psoriatic arthritis	0.000467	0.000949	CcSEcCtD
Oxybutynin—Discomfort—Methotrexate—psoriatic arthritis	0.000467	0.000949	CcSEcCtD
Oxybutynin—Constipation—Prednisone—psoriatic arthritis	0.000463	0.000942	CcSEcCtD
Oxybutynin—Confusional state—Methotrexate—psoriatic arthritis	0.000457	0.000928	CcSEcCtD
Oxybutynin—Dizziness—Triamcinolone—psoriatic arthritis	0.000454	0.000922	CcSEcCtD
Oxybutynin—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000453	0.00092	CcSEcCtD
Oxybutynin—Dizziness—Methylprednisolone—psoriatic arthritis	0.000453	0.00092	CcSEcCtD
Oxybutynin—Infection—Methotrexate—psoriatic arthritis	0.00045	0.000914	CcSEcCtD
Oxybutynin—Feeling abnormal—Prednisone—psoriatic arthritis	0.000447	0.000907	CcSEcCtD
Oxybutynin—Asthenia—Betamethasone—psoriatic arthritis	0.000447	0.000907	CcSEcCtD
Oxybutynin—Asthenia—Dexamethasone—psoriatic arthritis	0.000447	0.000907	CcSEcCtD
Oxybutynin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000444	0.000903	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000443	0.000901	CcSEcCtD
Oxybutynin—Nausea—Prednisolone—psoriatic arthritis	0.000443	0.0009	CcSEcCtD
Oxybutynin—Pruritus—Dexamethasone—psoriatic arthritis	0.00044	0.000895	CcSEcCtD
Oxybutynin—Pruritus—Betamethasone—psoriatic arthritis	0.00044	0.000895	CcSEcCtD
Oxybutynin—Skin disorder—Methotrexate—psoriatic arthritis	0.00044	0.000894	CcSEcCtD
Oxybutynin—Vomiting—Triamcinolone—psoriatic arthritis	0.000436	0.000886	CcSEcCtD
Oxybutynin—Vomiting—Methylprednisolone—psoriatic arthritis	0.000435	0.000884	CcSEcCtD
Oxybutynin—Rash—Triamcinolone—psoriatic arthritis	0.000432	0.000879	CcSEcCtD
Oxybutynin—Dermatitis—Triamcinolone—psoriatic arthritis	0.000432	0.000878	CcSEcCtD
Oxybutynin—Anorexia—Methotrexate—psoriatic arthritis	0.000432	0.000877	CcSEcCtD
Oxybutynin—Rash—Methylprednisolone—psoriatic arthritis	0.000432	0.000877	CcSEcCtD
Oxybutynin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000431	0.000876	CcSEcCtD
Oxybutynin—Urticaria—Prednisone—psoriatic arthritis	0.000431	0.000875	CcSEcCtD
Oxybutynin—Headache—Triamcinolone—psoriatic arthritis	0.00043	0.000873	CcSEcCtD
Oxybutynin—Headache—Methylprednisolone—psoriatic arthritis	0.000429	0.000871	CcSEcCtD
Oxybutynin—Abdominal pain—Prednisone—psoriatic arthritis	0.000428	0.000871	CcSEcCtD
Oxybutynin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000426	0.000865	CcSEcCtD
Oxybutynin—Diarrhoea—Betamethasone—psoriatic arthritis	0.000426	0.000865	CcSEcCtD
Oxybutynin—Hypotension—Methotrexate—psoriatic arthritis	0.000423	0.00086	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000413	0.000838	CcSEcCtD
Oxybutynin—Dizziness—Dexamethasone—psoriatic arthritis	0.000412	0.000836	CcSEcCtD
Oxybutynin—Dizziness—Betamethasone—psoriatic arthritis	0.000412	0.000836	CcSEcCtD
Oxybutynin—Insomnia—Methotrexate—psoriatic arthritis	0.00041	0.000832	CcSEcCtD
Oxybutynin—Nausea—Triamcinolone—psoriatic arthritis	0.000407	0.000828	CcSEcCtD
Oxybutynin—Paraesthesia—Methotrexate—psoriatic arthritis	0.000407	0.000826	CcSEcCtD
Oxybutynin—Nausea—Methylprednisolone—psoriatic arthritis	0.000407	0.000826	CcSEcCtD
Oxybutynin—Somnolence—Methotrexate—psoriatic arthritis	0.000403	0.000818	CcSEcCtD
Oxybutynin—Hypersensitivity—Prednisone—psoriatic arthritis	0.000399	0.000811	CcSEcCtD
Oxybutynin—Dyspepsia—Methotrexate—psoriatic arthritis	0.000399	0.00081	CcSEcCtD
Oxybutynin—Vomiting—Betamethasone—psoriatic arthritis	0.000396	0.000804	CcSEcCtD
Oxybutynin—Vomiting—Dexamethasone—psoriatic arthritis	0.000396	0.000804	CcSEcCtD
Oxybutynin—Decreased appetite—Methotrexate—psoriatic arthritis	0.000394	0.0008	CcSEcCtD
Oxybutynin—Rash—Betamethasone—psoriatic arthritis	0.000392	0.000797	CcSEcCtD
Oxybutynin—Rash—Dexamethasone—psoriatic arthritis	0.000392	0.000797	CcSEcCtD
Oxybutynin—Dermatitis—Dexamethasone—psoriatic arthritis	0.000392	0.000797	CcSEcCtD
Oxybutynin—Dermatitis—Betamethasone—psoriatic arthritis	0.000392	0.000797	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000391	0.000795	CcSEcCtD
Oxybutynin—Fatigue—Methotrexate—psoriatic arthritis	0.000391	0.000793	CcSEcCtD
Oxybutynin—Headache—Dexamethasone—psoriatic arthritis	0.00039	0.000792	CcSEcCtD
Oxybutynin—Headache—Betamethasone—psoriatic arthritis	0.00039	0.000792	CcSEcCtD
Oxybutynin—Asthenia—Prednisone—psoriatic arthritis	0.000389	0.00079	CcSEcCtD
Oxybutynin—Pain—Methotrexate—psoriatic arthritis	0.000387	0.000787	CcSEcCtD
Oxybutynin—Pruritus—Prednisone—psoriatic arthritis	0.000383	0.000779	CcSEcCtD
Oxybutynin—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000373	0.000758	CcSEcCtD
Oxybutynin—Diarrhoea—Prednisone—psoriatic arthritis	0.000371	0.000753	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00037	0.000753	CcSEcCtD
Oxybutynin—Nausea—Dexamethasone—psoriatic arthritis	0.00037	0.000751	CcSEcCtD
Oxybutynin—Nausea—Betamethasone—psoriatic arthritis	0.00037	0.000751	CcSEcCtD
Oxybutynin—Urticaria—Methotrexate—psoriatic arthritis	0.00036	0.000731	CcSEcCtD
Oxybutynin—Dizziness—Prednisone—psoriatic arthritis	0.000358	0.000728	CcSEcCtD
Oxybutynin—Abdominal pain—Methotrexate—psoriatic arthritis	0.000358	0.000728	CcSEcCtD
Oxybutynin—Vomiting—Prednisone—psoriatic arthritis	0.000345	0.0007	CcSEcCtD
Oxybutynin—Rash—Prednisone—psoriatic arthritis	0.000342	0.000694	CcSEcCtD
Oxybutynin—Dermatitis—Prednisone—psoriatic arthritis	0.000341	0.000694	CcSEcCtD
Oxybutynin—Headache—Prednisone—psoriatic arthritis	0.00034	0.00069	CcSEcCtD
Oxybutynin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000334	0.000678	CcSEcCtD
Oxybutynin—Asthenia—Methotrexate—psoriatic arthritis	0.000325	0.00066	CcSEcCtD
Oxybutynin—Nausea—Prednisone—psoriatic arthritis	0.000322	0.000654	CcSEcCtD
Oxybutynin—Pruritus—Methotrexate—psoriatic arthritis	0.00032	0.000651	CcSEcCtD
Oxybutynin—Diarrhoea—Methotrexate—psoriatic arthritis	0.00031	0.00063	CcSEcCtD
Oxybutynin—Dizziness—Methotrexate—psoriatic arthritis	0.0003	0.000609	CcSEcCtD
Oxybutynin—Vomiting—Methotrexate—psoriatic arthritis	0.000288	0.000585	CcSEcCtD
Oxybutynin—Rash—Methotrexate—psoriatic arthritis	0.000286	0.00058	CcSEcCtD
Oxybutynin—Dermatitis—Methotrexate—psoriatic arthritis	0.000285	0.00058	CcSEcCtD
Oxybutynin—Headache—Methotrexate—psoriatic arthritis	0.000284	0.000577	CcSEcCtD
Oxybutynin—Nausea—Methotrexate—psoriatic arthritis	0.000269	0.000547	CcSEcCtD
